Literature DB >> 3162340

Fine specificity and idiotype diversity of the murine anti-HLA-A2, A28 monoclonal antibodies CR11-351 and KS1.

M Tsujisaki1, K Sakaguchi, M Igarashi, P Richiardi, F Perosa, S Ferrone.   

Abstract

The monoclonal antibodies (MoAb) CR11-351 and KS1 are secreted by hybridomas generated with splenocytes from BALB/c mice immunized with the cultured human B lymphoid cells LG-2 (HLA-A2,A2,B27,B27). The 2 monoclonal antibodies immunoprecipitated components with a superimposable 2-dimensional gel electrophoretic profile from the cultured B lymphoid cells LG-2 and inhibited the cytotoxicity of the anti-HLA-A2,A28 T cell clone MI#3 to a similar extent. In crossinhibition experiments, the MoAb CR11-351 and KS1 completely inhibited the binding of each other to lymphoid cells with the appropriate HLA phenotype. Testing with a panel of HLA-typed lymphoid cells showed that the MoAb CR11-351 and KS1 display the same serologic specificity, since both of them react with HLA-A2 and/or A28 antigens bearing cells. The 2 monoclonal antibodies recognize distinct, although spatially close, determinants, since only the MoAb CR11-351 displays differential reactivity with HLA-A2 variant cell lines and reacts with HLA-A9 bearing B lymphoid cells. Analysis of MoAb CR11-351 and KS1 with syngeneic polyclonal and monoclonal antiidiotypic antibodies detected no sharing of idiotopes between the 2 monoclonal antibodies. In view of their reactivity with distinct determinants, these results are in agreement with the concept that the antigenic specificity of an antibody controls at least in part the expression of its idiotypes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3162340     DOI: 10.1097/00007890-198803000-00026

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  8 in total

1.  Quantification of soluble HLA class I gene products by an enzyme linked immunosorbent assay.

Authors:  I Doxiadis; U Westhoff; H Grosse-Wilde
Journal:  Blut       Date:  1989-11

2.  Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy.

Authors:  Chien-Chung Chang; Michael Campoli; Nicholas P Restifo; Xinhui Wang; Soldano Ferrone
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

3.  Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.

Authors:  Carmen Visus; Yangyang Wang; Antonio Lozano-Leon; Robert L Ferris; Susan Silver; Miroslaw J Szczepanski; Randall E Brand; Cristina R Ferrone; Theresa L Whiteside; Soldano Ferrone; Albert B DeLeo; Xinhui Wang
Journal:  Clin Cancer Res       Date:  2011-08-19       Impact factor: 12.531

4.  Identification of Hydroxysteroid (17β) dehydrogenase type 12 (HSD17B12) as a CD8+ T-cell-defined human tumor antigen of human carcinomas.

Authors:  Carmen Visus; Diasuke Ito; Rajiv Dhir; Miroslaw J Szczepanski; Yoo Jung Chang; Jean J Latimer; Stephen G Grant; Albert B DeLeo
Journal:  Cancer Immunol Immunother       Date:  2011-03-16       Impact factor: 6.968

5.  Targeting 11q23 positive acute leukemia cells with high molecular weight-melanoma associated antigen-specific monoclonal antibodies.

Authors:  Allison S Drake; Michael T Brady; Xin Hui Wang; Sheila J N Sait; Justin C Earp; Sampa Ghoshal Gupta; Soldano Ferrone; Eunice S Wang; Meir Wetzler
Journal:  Cancer Immunol Immunother       Date:  2008-08-02       Impact factor: 6.968

6.  Biased epitope selection by recombinant vaccinia-virus (rVV)-infected mature or immature dendritic cells.

Authors:  D Nagorsen; M Panelli; M E Dudley; S E Finkelstein; S A Rosenberg; F M Marincola
Journal:  Gene Ther       Date:  2003-09       Impact factor: 5.250

7.  Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells.

Authors:  Z Wang; F M Marincola; L Rivoltini; G Parmiani; S Ferrone
Journal:  J Exp Med       Date:  1999-07-19       Impact factor: 14.307

8.  Antimelanoma CTL recognizes peptides derived from an ORF transcribed from the antisense strand of the 3' untranslated region of TRIT1.

Authors:  Rolf K Swoboda; Rajasekharan Somasundaram; Laura Caputo-Gross; Francesco M Marincola; Paul Robbins; Meenhard Herlyn; Dorothee Herlyn
Journal:  Mol Ther Oncolytics       Date:  2015-01-14       Impact factor: 7.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.